The advisory committee's recommendation expands on the FDA's authorization of Pfizer vaccine boosters for people 65 and up. Both regulatory moves will inform the U.S. plan to dispense extra doses.
(Image credit: Matt Rourke/AP)
Subscribe to:
Post Comments
(
Atom
)
Post a Comment